Very high-dose focused radiation for early lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether a single, very high-dose focused radiation treatment can control early-stage lung cancer. It may help people who can’t or prefer not to have surgery, by delivering precise radiation to the tumor while aiming to spare nearby tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old and able to sign consent
- You must have early-stage lung cancer confirmed by biopsy/pathology or a lung-cancer team discussion
- Your general health score must be 0–1 (able to do most daily activities)
- Your screening blood tests must be adequate (white blood cells, platelets, and hemoglobin) and not require very recent blood/hemoglobin support
- Your liver, kidney, and clotting tests must meet specific safe limits
- You must not be in another treatment study right now and must be willing to follow the trial plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a more precise radiation technique (stereotactic body radiotherapy) for early-stage lung cancer or small lung tumors. It aims to reduce side effects by eliminating the usual safety margin around the tumor.
This trial tests a personalized radiation treatment called SBRT for early-stage non-small cell lung cancer that is located in the outer part of the lung and cannot be removed with surgery. The goal is to see if this approach works well for people who cannot have surgery or choose not to.
This trial studies how safe and effective a type of focused radiation called SBRT is for cancer tumors in certain chest locations. It’s meant for people whose tumor is small (up to 5 cm) and who don’t have widespread, uncontrolled spread.
This trial tests a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) with stereotactic body radiation therapy (SBRT) for people with early-stage non-small cell lung cancer. The goal is to see if this treatment can help shrink or control the cancer before surgery.
This trial tests how a single, high-dose radiation treatment (called SBRT) affects quality of life and outcomes for people with certain lung tumors. It's for adults with early-stage non-small cell lung cancer or a lung tumor that has spread from another cancer, as long as the tumor is small and in the outer part of the lung.
This trial studies a precise, high-dose radiation technique (SBRT) to treat tumors in the lungs. It may help control cancer in people who either have early-stage lung cancer that is not fully operable or have limited lung metastases from other cancers.
Hear when a new Early Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.